Personal information

Activities

Employment (1)

Hormozgan University of Medical Sciences: Bandar Abbas, IR

Employment
Source: Self-asserted source
Baran Roshan Nasrabad Sofla

Works (4)

Comparison of the Areas Under the Curve of Vancomycin Continuous vs. Intermittent Infusion in Critically Ill Pediatrics: A Randomized Clinical Trial

Iranian Journal of Pharmaceutical Research
2024 | Journal article
Contributors: Roshan, N. S. Baran; Mirrahimi, Bahador; Najmeddin, Farhad; Ahmadizadeh, Seyedeh Narjes; Behzad, Azita; Hashemi, Seyedeh Masumeh; Alemzadeh, Maryam; Taherpour, Niloufar
Source: check_circle
Web of Science Researcher Profile Sync

Study of the effects of interferon β−1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study

Journal of Medical Virology
2022 | Journal article
EID:

2-s2.0-85120179192

Part of ISSN: 10969071 01466615
Contributors: Fallahzadeh, M.; Pourhoseingholi, M.A.; Boroujeni, M.G.; Besharati, S.; Mardani, M.; Shabani, M.; Shokouhi, S.; Amirdosara, M.; Hajiesmaeili, M.; Gachkar, L. et al.
Source: Self-asserted source
Baran Roshan Nasrabad Sofla via Scopus - Elsevier
grade
Preferred source (of 2)‎

Efficacy of Interferon β-1a in Treatment of Hospitalized COVID-19 Patients; SBMU Taskforce on the COVIFERON Study

Research Square
2021 | Other
EID:

2-s2.0-85168172545

Contributors: Fallahzadeh, M.; Pourhoseingholi, M.A.; Besharati, S.; Boroujeni, M.G.; Mardani, M.; Shabani, M.; Shokouhi, S.; Amirdosara, M.; Hajiesmaeili, M.; Gachkar, L. et al.
Source: Self-asserted source
Baran Roshan Nasrabad Sofla via Scopus - Elsevier
grade
Preferred source (of 2)‎

Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review

International Immunopharmacology
2021 | Journal article
EID:

2-s2.0-85105338079

Part of ISSN: 18781705 15675769
Contributors: Shokouhi, S.; Barati, S.; Kazeminia, N.; Jamali, F.; Roshan, B.; Sahraei, Z.
Source: Self-asserted source
Baran Roshan Nasrabad Sofla via Scopus - Elsevier
grade
Preferred source (of 2)‎